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Abstract
During G1 to S phase transition, D-type cyclins form complexes with cyclin-dependent kinases (Cdk), which in turn
phosphorylate retinoblastoma gene product (Rb) and inhibit its growth-inhibitory function, leading ultimately to cell
proliferation. We report here a novel finding that D1 and D2 cyclins are induced in macrophages by antiproliferative factor
gamma interferon (IFNQ). The induction appears to be transcriptional activation of the D cyclin genes, since indirect events
such as IFNQ-induced colony-stimulating factor-1 (CSF-1) autocrine stimulation, alteration of D1 and D2 mRNA stability
and lipopolysaccharide contamination in commercial IFNQ preparations play no roles. In contrast to CSF-1, IFNQ neither
induces D1^Cdk4 complex formation and Rb hyperphosphorylation nor interferes with CSF-1-stimulated D1^Cdk4
interaction and Rb phosphorylation, while it completely blocks CSF-1-stimulated cell proliferation. This study suggests that
induction of D1 and D2 cyclins is not necessarily associated with cell cycle progression, and D cyclins may have cell cycle-
independent functions in response to IFNQ. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Serum and growth factors stimulate cell prolifera-
tion by driving cells from the G1 to the S phase of
the cell cycle [15]. A crucial event during the G1 to S
transition is induction of D-type cyclins (D1, D2 and
D3). The levels of D-type cyclins remain low or un-
detectable in cells at G0 or at the beginning of G1,
and are dramatically elevated in cells as delayed early
genes in a cycloheximide (CHX)-sensitive manner fol-
lowing serum or growth factor treatment. Newly syn-
thesized D-type cyclins form complexes with cyclin-
dependent kinases (Cdk), Cdk4 and Cdk6, which in
turn become activated following dephosphorylation
by Cdc25A and phosphorylation by CAK (Cdk-acti-
vating kinase) [15]. A well-established substrate for
D1^Cdk4 kinase is the retinoblastoma gene product
(Rb), which acts as a negative regulator of cell cycle
progression. Hyperphosphorylation of Rb by D1^
Cdk4 kinase causes its dissociation from E2F, a family
of transcription factors that activate the transcription
of genes involved in further cell cycle progression [18].
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Apart from the positive roles that D-type cyclins
play in cell cycle progression, a number of recent
studies have shown that D-type cyclins also perform
Cdk-independent functions and, in certain cell types,
even prevent Cdks from activation. For example,
overexpression of D1 alone inhibited ¢broblast entry
into the S phase [12,13]. Enforced overexpression of
D1 in mouse mammary epithelial cells also delays S
phase entry and cell growth [9]. This appears to be
due to D1-mediated induction of the cell cycle inhib-
itor p27kip1 [8]. There is a correlation between nerve
growth factor-induced cell growth arrest/neurite out-
growth and D1 gene expression in the absence of
Cdk activation in the pheochromocytoma cell line
PC12 [17,19]. The above studies suggest that, de-
pending upon cell stage, cellular contexts and up-
stream signals, D-type cyclins can carry out distinct
functions.
Among the three major classes of interferons
(IFN), leukocyte or IFN-K, ¢broblast or IFN-L
(type I) and immune or IFN-Q (type II), IFN-Q is
the most important immunomodulatory IFN
[5,6,14]. It induces the major histocompatibility com-
plex class I and class II regions, regulates isotype
expressions of immunoglobulins, activates monocytes
and macrophages and executes anti-viral, anti-tumor,
antiproliferative and phagocytotic e¡ects. In fact,
IFNQ represents the major activity of macrophage
activating factor (MAF) in tumor cytotoxicity
[1,4,14]. IFNQ binds and activates its receptor at
the cell surface, which then activates Jak1 and Jak2
protein tyrosine kinases on the cytoplasmic face of
the membrane. The Jak kinases phosphorylate the
receptor’s cytoplasmic tail on its tyrosine residues,
which in turn serve as binding sites for the SH2 do-
main of STAT1 (signal transducers and activators of
transcription 1). STAT1 binds to the receptor and
becomes phosphorylated by the Jak kinases. The ty-
rosine phosphorylated STAT1 proteins dimerize via
interchain head-to-tail phosphotyrosine-SH2 binding,
translocate to the nucleus and initiate transcription
of target genes [4]. Jak and STAT represent two
multiple-gene families that play diverse roles in sig-
naling in response to a variety of hormones, growth
factors and cytokines. In the course of studying the
mechanisms by which IFNQ inhibits proliferation and
stimulates activation and di¡erentiation of macro-
phages, we surprisingly found that IFNQ induces ex-
pression of D1 and D2 genes. In contrast to colony-
stimulating factor-1 (CSF-1) stimulation, IFNQ by
itself did not cause D1^Cdk4 kinase complex forma-
tion and Rb hyperphosphorylation. Moreover, IFNQ
did not inhibit CSF-1-stimulated D1^Cdk4 complex
formation and Rb hyperphosphorylation. Moreover,
induction of D1 and D2 by IFNQ was found predom-
inantly in macrophage cells. These results suggest
that the D-type cyclins induced by IFNQ play cell
cycle-independent functions in macrophages.
2. Materials and methods
Mouse CSF-1 and goat anti-mouse CSF-1 mono-
clonal antibody were kindly provided by E. Richard
Stanley (Albert Einstein College of Medicine, New
York, USA). Murine and human recombinant
IFNQ were purchased from Gibco BRL (Gaithers-
berg, MD, USA). Mouse cyclin D1 and cyclin D2
cDNAs and anti-D1 (B35) and anti-D2 (mAbD2-
34B4-7) antibodies were gifts from Dr. Martine
Roussel (St. Jude Children’s Research Hospital,
Memphis, TN, USA). Monoclonal anti-D1 antibody
(D1-72-13G) was purchased from Zymed Laborato-
ries (South San Francisco, CA, USA). Anti-Cdk4
antibody (Cdk4-M) was a gift from Dr. Xiong Yue
(University of North Carolina, Chapel Hill, NC,
USA) and was used as described previously [7].
Anti-human Rb antibody (G3-245) was purchased
from Pharmingen (San Diego, CA, USA). 125I-pro-
tein A (70^100 mCi/mg) was purchased from ICN
Biomedicals (Costa Mesa, CA, USA). Horse-radish
peroxide (HRP) conjugated anti-mouse IgG (NA931)
and enhanced chemiluminescence (ECL) reagents
were purchased from Amersham Life Science.
2.1. Cell culture and treatments
Murine Bac1.2F5 macrophage cell line and bone
marrow-derived macrophages (BMM) (see below)
were grown in alpha medium (Gibco BRL) supple-
mented with 10% (v/v) heat-inactivated fetal bovine
serum (FBS), penicillin G (50 U/ml), streptomycin
sulfate (50 Wg/ml) and 10% (v/v) L cell-conditioned
medium as the source of murine CSF-1 [10]. Prior to
CSF-1 (10 000 units/ml) or IFNQ (100 units/ml) treat-
ment, cells were incubated in CSF-1-free medium for
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16 h. Following treatment, cells were washed three
times with ice-cold phosphate-bu¡ered saline and im-
mediately subjected to either RNA isolation or cell
extract preparation. All other cell lines were cultured
in their previously designated media and starved
overnight in low serum (0.2%) medium, arresting
cells at G1, prior to IFNQ treatment.
2.2. Isolation of BMM
BMM were isolated and cultured as described else-
where [3]. Brie£y, femurs were removed aseptically
from mice and bone marrow was £ushed out using
a #23 gauge needle with ice cold alpha medium (5
ml/two femurs). To disperse the cells, the marrow
plug was gently passed through a #22 gauge needle
twice and then centrifuged at 913Ug (2000 rpm in
Beckman GS-6R) for 5 min at 4‡C. Cells were resus-
pended, counted and plated in 10% L cell condi-
tioned medium at a density of 1U106 cells/ml. After
24 h, non-adherent cells were pelleted and cultured in
fresh medium for two days. On day 3, non-adherent
cells were re-suspended in fresh medium following
centrifugation and incubated for two additional
days. Adherent cells, considered day 5 BMM, were
pooled and either frozen in liquid nitrogen for future
use or kept in culture for six additional days. For all
the experiments, day 11 BMM cells were deprived of
CSF-1 for 18^20 h and re-stimulated with mouse
CSF-1 or IFNQ for indicated times.
2.3. Assay for nitric oxide (NO) synthesis
Synthesis of NO was determined as previously de-
scribed [16]. Brie£y, 50 ml of culture supernatants
were reacted with an equal volume of Griess reagent
(0.5% sulfanilamide, 0.05% N-(1-naphthyl)ethylene-
diamine dihydrochloride in 2.5% H3PO4) in 96-well
tissue culture plates for 10 min at room temperature
in the dark. The optical densities of assayed samples
were measured on a Spectra MAX 250 (Molecular
Devices) plate reader at 550 nm. NO concentration
was calculated by comparing with a standard curve
of NaNO2.
2.4. Northern blot analysis
Total RNAs were isolated using a Qiagen RNeasy
kit. Equal amounts of RNA isolated from cells of
various treatments were size-fractionated on 1%
agarose gel containing 0.66 M formaldehyde, trans-
ferred to Duralon nylon membrane (Stratagene),
crosslinked to the membrane by UV and baked
under vacuum for 90 min at 80‡C. The membrane
was prehybridized in 50% formamide, 6USSPE, 10%
Dextran sulfate, 0.5% SDS, 5UDenhart and 100 Wg/
ml sheared salmon sperm DNA at 42‡C, then hy-
bridized in the same bu¡er in the presence of radio-
labeled cDNA probes. The membrane was washed
twice in 2USSC at 50‡C for 20 min and three times
in 0.2USSC, 0.1% SDS for 1 h at 60‡C. Between
hybridizations with di¡erent cDNA probes, the pre-
viously bound probes were stripped o¡ by boiling for
30 s in a solution of 0.1USSPE and 0.5% SDS and
shaking for 10 min at room temperature. The mem-
brane was rinsed twice in 1USSPE prior to pre-hy-
bridization.
2.5. Immunoprecipitation and Western blot analysis
Preparation of the cell lysates for immunoprecipi-
tation of the cyclins and Cdk proteins was carried
out as previously described [10]. The lysates (200^300
Wg protein) were immunoprecipitated with anti-D1
antibody (D1-72-13G, 5 Wg, 2 h at 4‡C) followed
by rabbit anti-mouse IgG antibody (10 Wg/ml, 1 h
at 4‡C). The immunoprecipitates were resolved by
SDS^PAGE, transferred to a nitrocellulose mem-
brane (MSI) and immunoblotted with either anti-
D1 (D1-72-13G) or anti-Cdk4 antibody (Cdk4-M).
The results were visualized by ECL (Amersham
Life Science). To detect D1 and Cdk4 protein levels
and Rb molecular weight shift, the total cell lysates
(30 Wg total proteins/lane) were resolved by SDS-
PAGE, transferred to a nitrocellulose membrane
and immunoblotted by anti-D1, anti-Cdk4 or anti-
Rb antibodies.
3. Results
3.1. IFNQ induces cyclins D1 and D2 while blocking
macrophage proliferation and inducing
macrophage activation
The mouse macrophage cell line Bac1.2F5 requires
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the continued presence of CSF-1 for survival and
proliferation. When CSF-1 is removed from the cul-
ture medium, these cells undergo growth arrest in G1
and subsequently die [11]. If they are transiently
starved in CSF-1-free medium and treated with
CSF-1, D1 and D2 (but not D3) genes are induced
and the cells re-enter synchronously through G1 into
the S phase [10]. An increase in the synthesis of NO,
a mediator of many macrophage cytotoxic functions,
represents an important hallmark of macrophage ac-
tivation in response to IFNQ [16]. To test whether or
not Bac1.2F5 cells show increased cellular NO syn-
thase activity in response to IFNQ, the NO concen-
tration in cultured supernatants was measured fol-
lowing IFNQ treatment. It is shown in Table 1 that
very little NO could be detected in untreated cells.
IFNQ alone and IFNQ plus LPS increased NO pro-
duction 40- and 300-fold, respectively. Thus, the
Bac1.2F5 cell line is an ideal cell culture system for
studying both cell cycle control and macrophage ac-
tivation.
In the course of studying the signaling mechanisms
by which IFNQ activates macrophages, we surpris-
ingly found that IFNQ, which blocks CSF-1-stimu-
lated proliferation, induces increased expression of
D1 and D2 cyclins in non-proliferating macrophage
cells. Total cellular RNA was isolated from Bac1.2F5
cells that were either untreated or treated with IFNQ
or CSF-1 (as a control) for di¡erent periods of times
and analyzed for expression of D1 and D2 by North-
ern blot analysis using radioactively-labeled D1 and
D2 cDNA probes. It is shown in Fig. 1A that a very
low level of D1 was detected in G1-arrested
Bac1.2F5 cells (lane 1). CSF-1 stimulation dramati-
cally increased D1 mRNA level (lane 2). Interest-
ingly, treatment with IFNQ alone also caused in-
creased expression of D1 in a time-dependent
manner (lanes 3 to 6). The IFNQ-induced appearance
of D1 mRNA occurred at around 5 h (lanes 3 and 4),
reached the maximum between 5 to 10 h (lanes 4 and
5) and declined to less than 40% of the maximum
induction by 20 h (lane 6). A similar result was ob-
tained when the same membrane was hybridized with
a D2 probe. As shown in Fig. 1B, IFNQ alone in-
duced similar kinetics of increased levels of D2
mRNA (lanes 3 to 6) and the level of induction
was comparable to CSF-1-stimulated D2 gene ex-
pression (lane 2). Equal amounts of total RNA sam-
ples were used as indicated by the levels of GAPDH
mRNA (Fig. 1C). Therefore, the kinetics of IFNQ-
induced D1 gene expression was slower than that of
CSF-1-stimulated D1 gene expression, in which the
appearance of increased D1 and D2 mRNA can be
seen by 1.5 h and the maximum induction is at 3 h
following addition of CSF-1 [10]. However, a similar
kinetics of D2 gene expression is shared by IFNQ and
CSF-1. It was reported that induction of the D2 gene
by CSF-1 occurred later (V5 h) than that of D1 (1.5
h) [10].
To con¢rm these ¢ndings in primary macrophages,
we carried out similar experiments using BMM. Day
11 BMM cells were deprived of CSF-1 (causing G1
arrest) for 20 h and incubated with CSF-1 or IFNQ
for 5 h. Total RNA was isolated and analyzed for
Table 1
IFNQ induces NO production in Bac 1.2f5 cells
Treatments Nitric oxide (WM þ S.D.)
Control 0.004 þ 0.02a
IFNQ 0.161 þ 0.03
IFNQ+LPS 1.186 þ 0.07
aMean values of quadruplicates from three independent experi-
ments.
Fig. 1. IFNQ induces expression of cyclin D1 and D2 in Bac1.2F5 and primary macrophages. Bac1.2F5 cells (A, B, C, G, H and I)
and mouse BMM (D, E and F) were G1-arrested in medium containing 10% FBS but in the absence of CSF-1 and either untreated
or treated with either CSF-1 (10 000 U/ml, 37‡C) or IFNQ (100 U/ml, 37‡C) for the indicated times. In some experiments (G, H and
I) cells were pretreated with or without cycloheximide (10 WM) for 15 min prior to CSF-1 or IFNQ treatment (+) or no treatment (3)
for 5 h. Total RNA was isolated and subjected (20 Wg/lane) to Northern blot analysis to measure D1 (A, D and G) and D2 (B, E
and H) gene expression. RNA loading was monitored by GAPDH mRNA levels (C, F and I). The speci¢c activity of 32P-labeled
DNA probes was V1U106 cpm/1 ng DNA and 1U106 cpm/ml was used in hybridization reactions. Exposure time: (A) 12 h; (B) 17
h; (C) 6 h; (D) 30 h; (E) 56 h; (F) 15 h; (G) 14 h; (H) 18 h and (I) 5 h. The fold increases (Ambis Scanning) were based on calibra-
tion with the corresponding GAPDH levels: band/band3UGAPDH3/GAPDH = fold. Results in (A) to (C), (D) to (F) and (G) to
(I) represent one of three, two and two independent experiments, respectively.
C
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D1 and D2 gene expression. It is shown in Fig. 1D
that the background level of D1 mRNA was low but
detectable in G1-arrested BMM cells (lane 1). CSF-1
stimulation caused a dramatic increase in D1 mRNA
(lane 2). IFNQ treatment induced a signi¢cant,
although less than CSF-1-stimulated, increase in D1
expression (lane 3). Interestingly, the CSF-1-stimu-
lated increase in D2 was barely detectable in BMM
cells (Fig. 1E, lane 2), but a relatively higher induc-
tion of D2 was detected in IFNQ-treated BMM cells
(lane 3). Approximately equal amounts of total RNA
were used in these experiments (Fig. 1F). Thus,
although there were quantitative di¡erences in D1
and D2 gene expression between Bac1.2F5 and
BMM cells in response to CSF-1 and IFNQ, induc-
tion of D1 and D2 by IFNQ was con¢rmed in BMM
cells.
To test whether de novo protein synthesis is re-
quired for the induction of D1 and D2 genes by
IFNQ, cells were pretreated with or without CHX
prior to IFNQ treatment (in the continued presence
of CHX). It is clearly shown in Fig. 1G that CSF-1
and IFNQ dramatically increased the level of D1
mRNA in the absence of CHX (lanes 2 and 3). How-
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Fig. 2. IFNQ appears to directly activate the expression of D1 and D2. (A to C) G1-arrested Bac1.2F5 cells were preincubated with
anti-CSF-1 neutralizing antibody (1:200 dilution by hybridoma-conditioned medium, Stanley, 1985) for 30 min prior to incubation
with CSF-1 (10 000 U/ml, 37‡C) or IFNQ (100 U/ml, 37‡C) in the continued presence of the anti-CSF-1 antibody for 4 h. Total RNA
was isolated and subjected (20 Wg/lane) to Northern blot analysis to measure D1 (A) and D2 (B) gene expression. GAPDH gene ex-
pression was included as RNA loading control (C). Exposure times: (A), (B), (D) and (E) 15 h; (C) and (F) 6 h. Results represent
one of two independent experiments. (D to G) G1-arrested Bac1.2F5 cells were ¢rst incubated with CSF-1 for 3 h. Following removal
of CSF-1, cells were washed and incubated in media containing actinomycin D (10 WM) for 30 min prior to addition of IFNQ for dif-
ferent periods of time in the continued presence of actinomycin D. Expression of D1 (D), D2 (E) and c-Myc (F) genes were analyzed,
as previously described. GAPDH (G) served as a control. Exposure times: (G) and (H) 12 h; (I) 16 h and (J) 8 h. Results represent
one of two independent experiments. (H to K) Detection of D1 and D2 gene expression was carried out as above except that cells
were treated with 16 pg/ml of LPS or CSF-1 (control). Results represent one of two independent experiments.
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ever, induction of D1 by both CSF-1 (lane 4) and
IFNQ (lane 5) was completely blocked in cells in the
presence of CHX. When the same blot was hybrid-
ized with D2 cDNA probe, as shown in Fig. 1H,
induction of D2 gene by CSF-1 or IFNQ was also
completely inhibited by CHX pretreatment (lanes 5
and 4 versus lanes 3 and 2). CHX alone had no e¡ect
on D1 and D2 mRNA levels (data not shown). Sim-
ilar amounts of total RNA were compared for this
experiment as indicated by GAPDH expression (Fig.
1I). These results suggest that induction of D1 and
D2 genes by CSF-1 and IFNQ requires de novo pro-
tein synthesis.
3.2. Induction of D1 and D2 by IFNQ appears to be
via transcriptional activation
An important question to us was whether or not
the increased expression of D1 and D2 by IFNQ was
due to direct transcriptional activation of the genes
by IFNQ or indirect e¡ects, such as autocrine e¡ects
of IFNQ-induced CSF-1 production, post-transcrip-
tional modi¢cation of pre-existing mRNA’s stability
or contaminated stimuli in the commercial IFNQ. We
tested the following three possible events: (1) CSF-1
autocrine loop (since CSF-1 is the required growth
factor for induction of cyclin D genes in macro-
phages and is absent in serum), (2) the modi¢cation
of the stability of the cyclin D mRNAs and (3) the
e¡ect of a residual amount of contaminated lipopoly-
saccharide (LPS) in commercial recombinant IFNQ
preparations.
First, it may be argued that IFNQ turns on tran-
scription of the CSF-1 gene in macrophage cells, re-
sulting in secretion of CSF-1 to the media and there-
by creating a CSF-1 autocrine loop. To examine this
possibility, anti-CSF-1 neutralizing antibodies were
added to the media to block CSF-1 signaling during
the entire period of IFNQ treatment. It is shown in
Fig. 2A,B that CSF-1 and IFNQ dramatically in-
duced expression of D1 (A, lanes 2 and 3) and D2
(B, lanes 2 and 3) genes. Anti-CSF-1 antibodies com-
pletely blocked the CSF-1-induced D1 (A, lane 4)
and D2 (B, lane 4) expression. However, the IFNQ-
induced expressions of D1 (A, lane 5) and D2 (B,
lane 5) were una¡ected. Equal amounts of total
RNA were used in the experiment (Fig. 2C). These
data clearly indicate that the induction of D1 and D2
genes by IFNQ was due to an IFNQ-speci¢c e¡ect.
Second, the argument that the increased D1 and
D2 mRNA levels in IFNQ-treated cells could be
due to enhanced stability of the D cyclin mRNAs
is highly unlikely, because there are low or undetect-
able levels of D1 and D2 gene expression in CSF-1-
starved Bac1.2F5 cells (see lanes 1 of Fig. 2A,B) and,
therefore, there is nothing to ‘accumulate’. One may
still argue that there is a high turnover rate of D
cyclin mRNAs and that IFNQ may decrease that
rate. Thus, we tested the possibility that IFNQ acts
by slowing down a high turnover rate of D cyclin
mRNAs (even in the G1-arrested macrophage cells).
Cells were ¢rst stimulated with CSF-1 to induce the
synthesis of D1 and D2 mRNAs. CSF-1 was then
removed and cells were incubated in media contain-
ing actinomycin D (10 WM, 30 min) to prevent fur-
ther transcription prior to the addition of IFNQ for
di¡erent periods of time. The degradation of D1, D2
and c-Myc mRNAs was analyzed. It is shown in Fig.
2D^F that CSF-1 stimulation caused an increase in
D1 (D), D2 (E) and c-Myc (F) mRNA levels (lanes 2
versus lanes 1). Upon removal of CSF-1 and addi-
tion of actinomycin D, the mRNA levels of D1 (D)
and D2 (E) declined, albeit slowly, in a time-depen-
dent manner (lanes 3 to 5). c-Myc mRNA rapidly
declined (F), indicating that c-Myc mRNA is less
stable than the D1 and D2 mRNAs. The presence
of IFNQ, however, did not a¡ect the stability of any
of the mRNAs tested (lanes 6 to 8). GAPDH gene
expression was used as the RNA loading control
(Fig. 2G). These results suggest that the increased
cyclin D expression in IFNQ-treated cells was not
due to the accumulation of pre-existing cyclin D
mRNAs caused by their slowed turnover. Third, it
was noticed that commercial IFNQ preparations are
contaminated with a small amount of LPS (1.6 pg/
100 U IFNQ, Gibco RBL). To make sure that the
induction of the D1 and D2 genes by IFNQ was
not due to the presence of the contaminated LPS,
Bac1.2F5 cells were incubated with 1.6 pg/ml of
LPS for 5 h and tested for D1 and D2 mRNA levels.
LPS had no e¡ect on the expression of D1 (Fig. 2H,
lane 2), D2 (Fig. 2I, lane 2) or c-Myc (Fig. 2J, lane 2)
genes. While de¢nitive conclusions await further
studies on D1 and D2 gene promoters, the above
studies suggest that IFNQ stimulates transcriptional
activation of the D1 and D2 genes.
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3.3. IFNQ-induced D1 protein neither forms a complex
with Cdk4 kinase nor causes Rb
hyperphosphorylation
To study whether or not the IFNQ-induced D-type
cyclins are functionally di¡erent from those induced
by CSF-1, we focused on D1 because its interaction
with Cdk4 kinase, which in turn phosphorylates Rb,
has been well-established [15]. We tested whether
IFNQ-induced D1 forms a complex with Cdk4 ki-
nase. To determine the time point at which the max-
imum induction of D1 protein by IFNQ is achieved,
total lysates of cells treated with or without IFNQ for
di¡erent times were subjected to Western blot anal-
ysis using an anti-D1 antibody. It is shown in Fig.
3A that IFNQ induced an increase in D1 protein
levels in a time-dependent manner, reaching the max-
imum level by 5 h (lanes 3). The CSF-1-stimulated
cells were included as a positive control (lane 6).
When a duplicate membrane was blotted with anti-
Cdk4 antibody, as shown in Fig. 3B, a similar level
of Cdk4 protein was detected, irrespective of the
IFNQ or CSF-1 treatment. To determine the associ-
ation between D1 and Cdk4, the lysates of cells,
either untreated or treated with CSF-1 or IFNQ,
were immunoprecipitated with anti-D1 antibody.
The immunoprecipitates were resolved by an SDS
gel, transferred to a nitrocellulose membrane and
immunoblotted with anti-Cdk4 antibody. It is shown
in Fig. 3C that no Cdk4 protein was found in the
anti-D1 antibody immunoprecipitate of the untreated
cells (lane 1). As expected, CSF-1 stimulation caused
co-immunoprecipitation of Cdk4 with D1 (lane 2).
Interestingly, no detectable Cdk4 was found in the
anti-D1 antibody immunoprecipitates of IFNQ-
treated cells (lane 3). It is noticed that the IFNQ-
induced D1 was less than the CSF-1-induced D1
from a similar number of cells (Fig. 3A, lanes 3, 4
and 5 versus lane 6) and, therefore, it is possible that
a larger number of cells would be required for detect-
ing the D1^Cdk4 complex in response to IFNQ. We
did not detect any interaction of D1 with Cdk4 even
upon using ¢ve times more cells (data not shown).
Total cell lysate was included as a control for the
anti-Cdk4 antibody blotting (lane 4). To further con-
¢rm this ¢nding, we used Rb hyperphosphorylation
as an alternative readout. It has been well-established
that the D1^Cdk4 kinase complex phosphorylates
6
Fig. 3. IFNQ does not cause D1^Cdk4 complex formation or
Rb hyperphosphorylation. (A and B) Total cell extracts (25 Wg/
lane) of Bac1.2F5 cells, untreated (3) or treated (+) with CSF-
1 (lane 6) or IFNQ (lanes 2 to 5) for the indicated times, were
resolved in an SDS gel, transferred to a nitrocellulose mem-
brane and immunoblotted with either anti-D1 (A) or anti-Cdk4
(B) antibodies. (C) The same cell lysates (200 Wg/lane, 8 h
IFNQ-treated cell lysate was used) were immunoprecipitated
with anti-D1 antibody, resolved together with a total lysate
(TL) as control in an SDS gel, transferred to a nitrocellulose
membrane and immunoblotted with anti-Cdk4 antibody (IgGh,
immunoglobulin G heavy chains). (D) The same cell lysates
used in (C) were resolved in an SDS gel, transferred to a nitro-
cellulose membrane and immunoblotted with anti-Rb antibody
to detect the Rb mobility shift. Results of (A) were visualized
by ECL and results of (B), (C) and (D) were visualized by incu-
bating with 125I-labeled protein A and using autoradiography.
The pRb/Rb ratios re£ect upper band/lower band Ambis Scan-
ning data. Exposure times: (A) 15 min; (B) 15 h; (C) 11 h and
(D) 16 h. Results represent one of three (A, B and C) or four
(D) independent experiments.
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Rb, resulting in the generation of a slower migrating,
hyperphosphorylated form of Rb. It is shown in Fig.
3D that in G1-arrested Bac1.2F5 cells, the majority
of Rb protein remains as a faster migrating form
(lane 1). IFNQ-treatment did not generate the hyper-
phosphorylated form of Rb (lane 2), whereas CSF-1
stimulation signi¢cantly increased the ratio of the
upper hyperphosphorylated Rb to the lower hypo-
phosphorylated Rb (lane 3, also see Fig. 5F). This
experiment again suggests that IFNQ does not stim-
ulate D1^Cdk4 kinase activity.
3.4. IFNQ does not interfere with CSF-1-stimulated
D1 expression, D1 association with Cdk4 or
hyperphosphorylation of Rb
To study possible functions of IFNQ-induced D1
cyclin, we asked whether or not IFNQ interferes with
CSF-1-stimulated D1 expression, D1^Cdk4 complex
formation and Rb hyperphosphorylation, thereby
blocking CSF-1-stimulated cell growth. Total RNA
was isolated from the cells, either untreated or
treated with CSF-1 alone or with CSF-1 and IFNQ
together and subjected to Northern blot analysis for
D1 and D2 expression. It is shown in Fig. 4 that
CSF-1 alone dramatically induced expression of
both the D1 (A, lane 2) and D2 (B, lane 2) genes.
Interestingly, the presence of IFNQ showed no inhib-
itory e¡ects on CSF-1-stimulated D1 (A) and D2 (B)
gene expression (lanes 3 to 5). Instead, IFNQ had a
synergistic e¡ect with CSF-1 on D1 (A) and partic-
ularly D2 (B) induction (lanes 4 versus lanes 2).
These results were reproducible in three independent
experiments. Second, we examined whether the pres-
Fig. 4. IFNQ does not interfere with CSF-1-stimulated D1 and D2 expression, D1^Cdk4 association or hyperphosphorylation of Rb.
(A to C) G1-arrested Bac1.2F5 cells were either untreated (3) or treated (+) with CSF-1 alone or CSF-1 plus IFNQ for the indicated
times. Total RNA was isolated and subjected (20 Wg/lane) to Northern blot analysis for D1 and D2 gene expression (A and B).
GAPDH mRNA levels were included as a RNA loading control (C). Exposure times: (A) 12 h; (B) 26 h and (C) 8 h. (D and E) Ly-
sates of Bac1.2F5 cells treated with (+) or without (3) CSF-1, or CSF-1 plus IFNQ, or pretreated with IFNQ (IFNQ-Pre) for 1 h prior
to addition of CSF-1 were immunoprecipitated with anti-D1 antibody. The immunoprecipitates were resolved in two SDS gels, trans-
ferred to nitrocellulose membranes and immunoblotted with either anti-D1 (D) or anti-Cdk4 antibody (E). Results of anti-D1 anti-
body blot were visualized by ECL and that of anti-Cdk4 antibody by 125I-labeled protein A, followed by autoradiography. (F) Total
lysates of cells either untreated or treated with CSF-1 or CSF-1 plus IFNQ for the indicated times were immunoblotted with anti-Rb
antibodies. Results were visualized by ECL, as previously described. The pRb/Rb ratios re£ect upper band/lower band Ambis Scan-
ning data. Results represent one of two (A to E) and four (F) independent experiments.
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ence of IFNQ interferes with CSF-1-stimulated D1^
Cdk4 complex formation and Rb hyperphosphoryla-
tion. Bac1.2F5 cells were either incubated simultane-
ously with IFNQ and CSF-1 or pre-incubated with
IFNQ for 1 h prior to the addition of CSF-1. Lysates
of cells were subjected to immunoprecipitation with
anti-D1 antibodies. Immunoprecipitates were re-
solved in an SDS gel, transferred to a nitrocellulose
membrane and immunoblotted with anti-Cdk4 anti-
bodies. It is shown in Fig. 4D that equal amounts of
D1 proteins were recovered by anti-D1 antibody im-
munoprecipitation from cells treated with CSF-1
(lanes 2 and 3), cells treated with CSF-1 plus IFNQ
(lanes 4 and 5) and cells pretreated with IFNQ (IFNQ-
Pre) then treated with CSF-1 (lanes 6 and 7). These
results indicate that IFNQ does not a¡ect CSF-1-
stimulated D1 protein synthesis. When a duplicate
membrane was immunoblotted with anti-Cdk4 anti-
body, as shown in Fig. 4E, equal amounts of Cdk4
were co-immunoprecipitated by anti-D1 antibodies
from both CSF-1-treated (lanes 2 and 3) and CSF-
1 plus IFNQ-treated (lane 4 to 7) cells. Moreover, the
kinase activity of D1^Cdk4 complexes was apparent-
ly high since IFNQ treatment did not block CSF-1-
stimulated Rb hyperphosphorylation (4F). Even in
the presence of IFNQ, CSF-1 was able to induce hy-
Fig. 5. Induced expression of D1 and D2 by IFNQ in various other cell lines. As indicated, di¡erent cell lines were incubated in low
serum (0.2%) for 20 h (to lower D cyclin levels) and either untreated (3) or treated (+) with murine or human IFNQ (100 U/ml,
37‡C) for 5 h. Total RNA was isolated and subjected to Northern blot analysis (5 to 30 Wg/lane, depending on the cell line) for D2
and/or D1 gene expression (A, B and D). GAPDH mRNA levels were included as an RNA loading control (C and E). Exposure
times: (A), (C) and (E) 20^28 h; (B), (D) and (F) 6^9 h. The fold increases (Ambis Scanning) were based on calibration with the cor-
responding GAPDH levels: band/band3UGAPDH3/GAPDH = fold. Results represent one of three independent experiments.
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perphosphorylation of Rb in a time-dependent fash-
ion (Fig. 4F, lanes 4 to 6). In contrast to a recent
report that IFNQ induces p21Waf1 in macrophages
[17], we could not detect any signi¢cant increase of
either p21Waf1 or p27 protein levels in Bac1.2F5 or
BMM cells in response to IFNQ or CSF-1. In con-
clusion, IFNQ does not interfere with the CSF-1-
stimulated D1^Cdk4-Rb-E2F pathway and the D
cyclins induced by IFNQ must play some yet-to-be
identi¢ed cell cycle-independent roles in macrophage
activation.
3.5. Induction of D-type cyclin genes by IFNQ in other
cell types
We next studied whether or not the induction of
D-type cyclin genes by IFNQ was a macrophage-spe-
ci¢c or general phenomenon in di¡erent cell types.
Ten di¡erent cell lines from human, rat and mouse
origins, including mouse NIH 3T3 ¢broblasts, mouse
FDC-P1 myeloid progenitor cells, rat RBL2H3 mast
cells, mouse A20 B lymphocytes, human prostate cell
line LNCAP, human cervical carcinoma cell line
HeLa, human prostate epithelial cell line PC3, hu-
man epidermoid carcinoma cell line A431, human
kidney embryonic cell line 293, rat pheochromcyto-
ma cell line PC12, and human lymphoma cells EL4,
were either untreated or treated with murine or hu-
man IFNQ and tested for D1 and D2 gene expres-
sion. CSF-1- and IFNQ-treated Bac1.2F5 cells were
included as positive controls. It is shown in Fig. 5
that IFNQ and CSF-1 induced D1 gene expression in
Bac1.2F5 cells (Fig. 5A, lanes 2 and 3). A much low-
er but reproducible induction of D1 was also de-
tected in IFNQ-treated A-20 B lymphocytes (Fig.
5A, lane 11 versus lane 10), A431 cells (Fig. 5D,
lane 8 versus lane 7) and EL4 cells (Fig. 5D, lane
12 versus 11). The rest of the cell lines showed no
change in D1 expression. Again, as expected, both
CSF-1 and IFNQ stimulated the expression of the D2
gene in Bac1.2F5 cells (Fig. 5B, lanes 2 and 3).
Among the cell lines tested for D2 gene expression
in response to IFNQ, FDC-P1 myeloid cells (Fig. 5B,
lane 7 versus lane 6) and A20 B lymphocytes (Fig.
5B, lane 11 versus lane 10) showed moderate in-
creases in D2 expression. Similar amounts of total
RNA were used for each individual cell line (Fig.
3C,E). These results show that a strong induction
of D-type cyclins by IFNQ occurred predominantly
in macrophages, whereas lower levels of induction
were seen in other cell types. Speci¢c induction of
the D cyclin genes in macrophages correlated with
the fact that macrophages are the major target in
vivo for IFNQ.
4. Discussion
In this study, we found that D1 and D2 cyclins are
induced by an anti-proliferative factor, MAF/IFNQ.
In the same cells, these genes are usually induced by
macrophage colony-stimulating factor mCSF/CSF-1
[10]. Our results show that (1) both growth-stimulat-
ing signal- and growth-inhibiting signal-mediated in-
duction require de novo protein synthesis and have
similar kinetics (D2 but not D1); (2) the induction of
D1 and D2 by IFNQ is much stronger in macro-
phages, although weaker induction is also seen in
other cell types; (3) IFNQ-induced D1 does not
form a complex with Cdk4 and IFNQ treatment
does not cause hyperphosphorylation of the Rb pro-
tein; (4) in the presence of IFNQ, CSF-1 is still able
to induce D1 synthesis, D1^Ckd4 complex formation
and hyperphosphorylation of Rb, while under these
conditions cell proliferation is completely blocked.
These results suggest that induction of the D cyclins
by IFNQ is not part of its antiproliferative action.
Our ¢nding that IFNQ does not interfere with CSF-
1-stimulated D1 and D2 expression was in con£ict
with a previous report by Cocks et al. [3], which
showed that IFNQ suppressed CSF-1-induced D1 ex-
pression in BMM cells. A major di¡erence between
the two studies is that we focused on 5^8 h treatment
with IFNQ (since most IFNQ-stimulated D1 and D2
induction declines after 20 h of IFNQ treatment),
whereas in the Cocks study, only a 22 h time period
was used. Moreover, the discrepancy is clearly not
due to di¡erences between Bac1.2F5 and BMM cells,
because we observed similar results in BMM cells
(Fig. 1D,E).
Results of our study suggest that IFNQ induces D1
and D2 cyclins through transcriptional activation of
the cyclin D genes. First, in the absence of CSF-1
(quiescent), the levels of D1 and D2 mRNAs are
undetectable in Bac1.2F5 and BMM cells. Therefore,
the fact that IFNQ induces D1 and D2 in G1-arrested
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cells makes it unlikely that it is due to indirect e¡ects
such as an increase in mRNA stability. Second, we
eliminate the possibility that IFNQ treatment turns
on the CSF-1 gene in the cells and creates a CSF-1
autocrine loop, since the presence of anti-CSF-1 anti-
bodies in the medium has no e¡ect on IFNQ-induced
D1 and D2 gene expression, whereas it completely
blocks CSF-1-stimulated D1 and D2 expression.
Third, the labels of commercial IFNQ preparations
(Gibco BRL) state that there is a trace amount of
LPS contamination in the preparations. We, there-
fore, suspected that the contaminating amount of
LPS may have contributed to the induction of D1
and D2 by IFNQ. However, upon treating the cells
with LPS alone (at trace contaminant levels and at
higher concentrations), we did not observe any in-
duction of D1 and D2 expression, indicating that
IFNQ itself is responsible for the induction. A de¢n-
itive answer for whether or not IFNQ acts on D1 and
D2 gene transcription would require studies of the
D1 and D2 promoters.
The ultimate question is what roles IFNQ-induced
D1 and D2 play in IFNQ-mediated activation and
di¡erentiation of macrophages. When CSF-1 and
IFNQ are simultaneously present, the anti-prolifera-
tive e¡ect of IFNQ overrides/suppresses the prolifer-
ative e¡ect of CSF-1. The mechanisms of IFNQ’s
anti-proliferative action remain unknown. Our study
suggests that it is not due to a blockade of CSF-1-
stimulated induction of cyclins, because IFNQ does
not interfere with CSF-1-induced D1 and D2 expres-
sion and D1^Cdk4 association. Several studies sug-
gested that p21Waf1 induction plays a role in IFNQ’s
anti-proliferative and anti-apoptotic e¡ects in macro-
phage and epidermal cells [2,19]. While we could de-
tect a moderate increase in p21Waf1 mRNA levels,
no increase in the p21Waf1 protein was observed,
even after anti-p21Waf1 immunoprecipitation of up
to 3U107 BMM or Bac1.2F5 cells (data not shown).
Under these conditions, a 5^7-fold increase in D1
protein levels in response to IFNQ was clearly de-
tected. Even if there is a low-level induction of
p21Waf1, it would be hard to imagine that it will be
stoichiometrically able to inhibit a much higher
amount of the D1^Cdk4 kinase complex. Further-
more, our results show that IFNQ does not block
CSF-1-stimulated Rb phosphorylation, suggesting
that the CSF-1-induced D1^Cdk4 kinase activity
is not inhibited. One possible function of the IFNQ-
induced D cyclins is the assistance of IFNQ-induced
transcription of the genes that are involved in macro-
phage activation and di¡erentiation. The current
study reveals new aspects of IFNQ signaling that
may play important biological roles in macrophages.
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